Results 71 to 80 of about 3,505 (170)

Review of underactive bladder

Journal of the Formosan Medical Association, 2018
In clinical practice, many patients cannot empty their bladders within an acceptable duration. Common complaints include weak urinary stream and incomplete emptying, which may affect quality of life.
Yi-Huei Chang, Justin Ji-Yuen Siu, Po-Jen Hsiao, Chao-Hsiang Chang, Eric Chieh-Lung Chou   +4 more
doaj   +1 more source

Population Pharmacokinetic and Pharmacodynamic Modeling of Fesoterodine in Pediatric Patients with Neurogenic Detrusor Overactivity. [PDF]

Eur J Drug Metab Pharmacokinet, 2023
Sano Y, Shoji S, Shahin M, Sweeney K, Darekar A, Malhotra BK.   +5 more
europepmc   +1 more source

Treatment of neurogenic detrusor overactivity and overactive bladder with Botox (onabotulinumtoxinA): Development, insights, and impact. [PDF]

Medicine (Baltimore), 2023
Nitti V, Haag-Molkenteller C, Kennelly M, Chancellor M, Jenkins B, Schurch B.   +5 more
europepmc   +1 more source

Long-term Safety and Tolerability of Repeated Treatments With OnabotulinumtoxinA in Children With Neurogenic Detrusor Overactivity. [PDF]

J Urol, 2023
Franco I, Hoebeke PB, Dobremez E, Titanji W, Geib T, Jenkins B, Yushmanova I, Austin PF.   +7 more
europepmc   +1 more source

Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity. [PDF]

Int Braz J Urol, 2022
Averbeck MA.
europepmc   +1 more source

Antimuscarinics for the treatment of neurogenic detrusor overactivity [PDF]

Spinal Cord, 2013
openaire   +3 more sources

Molecular Mechanism Operating in Animal Models of Neurogenic Detrusor Overactivity: A Systematic Review Focusing on Bladder Dysfunction of Neurogenic Origin. [PDF]

Int J Mol Sci, 2023
Ferreira A, Nascimento D, Cruz CD.
europepmc   +1 more source

Sacral neuromodulation success in a long-term multiple sclerosis patient with neurogenic bladder disorder and detrusor underactivity: a case report

African Journal of Urology
Background Multiple sclerosis (MS) is a leading cause of non-traumatic disability in young adults and is frequently associated with lower urinary tract symptoms (LUTS).
Karolina Garbas, Aleksandra Żuk-Łapan, Mateusz Mucha, Tomasz Piecha, Łukasz Zapała, Piotr Radziszewski   +5 more
doaj   +1 more source

Botulinum Toxin in Children and Adolescents—A Comprehensive Review of Clinical Applications

Toxins
Botulinum toxin, once known only as the cause of botulism, has become a versatile therapeutic agent whose use in children now extends across many medical and surgical specialties.
Marko Bašković, Vedrana Nikić Čižmek, Jana Buzuk, Bianka Dujić, Danijela Jurić, Kristina Jurković, Karla Pehar, Sara Vuković   +7 more
doaj   +1 more source

Percutaneous tibial nerve stimulation in the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: a historically controlled study. [PDF]

Ther Adv Urol, 2023
Carilli M, Pacini P, Serati M, Iacovelli V, Bianchi D, Petta F, Pastore S, Amato I, Fede Spicchiale C, D'Ippolito G, Pletto S, Cavaleri Y, D'Amico A, Parisi I, Finazzi Agrò E.   +14 more
europepmc   +1 more source